Analyst Ratings for Arcturus Therapeutics (ARCT)
ARCT Rating Summary
ARCT Price Target Summary
- Highest: $68.00 (Laidlaw)
- Lowest: $8.00 (Citi)
- Average: $24.75
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$24.75 (+248.1%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
Avg. $ Target:
$24.75 (+248.1%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/23/2026 | Roth/MKM | ADAM | New Coverage | Buy (N/A) |
20.00 (N/A) |
7.27 (7.11) |
-2.2% | Details |
| 10/24/2025 | H.C. Wainwright » Updated 11/12/2025 |
Andrew Fein | Downgrade | Neutral (Buy) |
9.00 (12.00) |
12.00 (7.11) |
-40.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
